Extraction, Purification, and Chemical Degradation of LPS from Gut Microbiota Strains
- PMID: 36587078
- DOI: 10.1007/978-1-0716-2910-9_13
Extraction, Purification, and Chemical Degradation of LPS from Gut Microbiota Strains
Abstract
It is estimated that more than 500 different bacterial species colonize the human gut, and they are collectively known as the gut microbiota. Such a massive bacterial presence is now considered an additional organ of the human body, thus becoming the object of an intense and daily growing research activity. Gram-negative bacteria represent a large percentage of the gut microbiota strains. The main constituent of the outer membrane of Gram-negatives is the lipopolysaccharide (LPS). Since its first discovery, LPS has been extensively studied for its structure-dependent capability to elicit a potent immune inflammatory reaction when perceived by specific immune receptors present in our body. Therefore, traditionally, LPS, due to its peculiar chemistry, has been associated with pathogenic bacteria, and it has been extensively studied for its dangerous effects on human health. However, LPS is also expressed on the cell surface of harmless and beneficial bacteria that colonize our intestines. This necessarily implies that the LPS from harmless gut microbes is "chemically different" from that owned by pathogenic ones, hence enabling successful colonization of the intestinal tract without creating a threat to the host immune system. Deciphering the structural features of LPS from these gut bacteria is essential to improve our still scarce knowledge of how the human host lives in a harmonious relationship with its own microbiota. To this end, LPS extraction and purification are essential steps in this field of research. Yet working with gut bacteria is extremely complex for a number of reasons, one being related to the fact that they produce an array of other glycans and glycoconjugates, such as capsular polysaccharides and/or exopolysaccharides, which render the isolation and characterization of the sole LPS not at all trivial. Here, we provide a protocol that might help when dealing with LPS from gut microbial species. We describe the preliminary manipulations and checks, extraction, and purification approaches, as well as the necessary chemical manipulations that should be performed to enable the characterization of the structure of an LPS by means of techniques like nuclear magnetic resonance spectroscopy and mass spectrometry.
Keywords: Chemical degradations of glycoconjugates; Extraction of glycoconjugates; Gut microbiota; Lipopolysaccharides (LPS); Purification of glycoconjugates.
© 2023. The Author(s), under exclusive license to Springer Science+Business Media, LLC, part of Springer Nature.
Similar articles
-
Lipopolysaccharide structures of Gram-negative populations in the gut microbiota and effects on host interactions.FEMS Microbiol Rev. 2019 May 1;43(3):257-272. doi: 10.1093/femsre/fuz002. FEMS Microbiol Rev. 2019. PMID: 30649292 Review.
-
Fecal Bacteria Implicated in Biofilm Production Are Enriched and Associate to Gastrointestinal Symptoms in Patients With APECED - A Pilot Study.Front Immunol. 2021 Jul 22;12:668219. doi: 10.3389/fimmu.2021.668219. eCollection 2021. Front Immunol. 2021. PMID: 34367134 Free PMC article.
-
Role of microbiota-derived lipopolysaccharide in adipose tissue inflammation, adipocyte size and pyroptosis during obesity.Nutr Res Rev. 2018 Dec;31(2):153-163. doi: 10.1017/S0954422417000269. Epub 2018 Jan 24. Nutr Res Rev. 2018. PMID: 29362018 Review.
-
Total Lipopolysaccharide from the Human Gut Microbiome Silences Toll-Like Receptor Signaling.mSystems. 2017 Nov 14;2(6):e00046-17. doi: 10.1128/mSystems.00046-17. eCollection 2017 Nov-Dec. mSystems. 2017. PMID: 29152585 Free PMC article.
-
Lipopolysaccharides derived from gram-negative bacterial pool of human gut microbiota promote inflammation and obesity development.Int Rev Immunol. 2022;41(1):45-56. doi: 10.1080/08830185.2021.1996573. Epub 2021 Nov 2. Int Rev Immunol. 2022. PMID: 34726960 Review.
Cited by
-
The chemistry of gut microbiome-derived lipopolysaccharides impacts on the occurrence of food allergy in the pediatric age.Front Mol Biosci. 2023 Oct 13;10:1266293. doi: 10.3389/fmolb.2023.1266293. eCollection 2023. Front Mol Biosci. 2023. PMID: 37900913 Free PMC article.
-
Bucking the trend: understanding lipopolysaccharide structure and outer membrane dynamics in cold-adapted Pseudomonas isolated from Enigma Lake, Antarctica.Chem Sci. 2024 Sep 18;15(43):17852-61. doi: 10.1039/d4sc05116e. Online ahead of print. Chem Sci. 2024. PMID: 39328195 Free PMC article.
-
Structure of the Lipopolysaccharide from : A Chemical Perspective on Immune Recognition.JACS Au. 2025 Jun 24;5(7):3311-3327. doi: 10.1021/jacsau.5c00441. eCollection 2025 Jul 28. JACS Au. 2025. PMID: 40747034 Free PMC article.
References
-
- Surana NK, Kasper DL (2014) Deciphering the tête-à-tête between the microbiota and the immune system. J Clin Invest 124(10):4197–4203. https://doi.org/10.1172/JCI72332 - DOI
-
- Di Lorenzo F, De Castro C, Silipo A, Molinaro A (2019) Lipopolysaccharide structures of gram-negative populations in the gut microbiota and effects on host interactions. FEMS Microbiol Rev 43(3):257–272. https://doi.org/10.1093/femsre/fuz002 - DOI
-
- The Human Microbiome Project Consortium (2012) Structure, function and diversity of the healthy human microbiome. Nature 486:207–214. https://doi.org/10.1038/nature11234 - DOI
-
- Eckburg PB, Bik EM, Bernstein CN, Pirani A, Atherly T, Jimenez R, Terrapon N, Henrissat B, Peterson D, Ziemer C, Snitkin E, Martens EC (2005) Diversity of the human intestinal microbial Flora. Science 308(5728):1635. https://doi.org/10.1126/science.1110591 - DOI
-
- Lee YK, Mehrabian P, Boyajian S, Wu W-L, Selicha J, Vonderfecht S, Mazmanian SK (2018) The protective role of Bacteroides fragilis in a murine model of colitis-associated colorectal cancer. mSphere 3(6):e00587–e00518. https://doi.org/10.1128/mSphere.00587-18 - DOI
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources